Fondazione Paracelso welcomes the development of biological, clinical and pharmaceutical research in the area of hemophilia and congenital haemorrhagic diseases. It establishes meaningful relationships with research groups, organisations and companies involved in this work.
Many of our initiatives have attracted businesses and istitutional partners who have seen the worth of our ideas. Thus for some projects we have accepted targeted funding without conditions attached. Obviously, acknowledgement of sponsors cannot be taken as advertising for a brand or product.
(From the Transparency document approved 19 December 2008).
Bayer
Biomarin
BioviiiX
CSL Behring
Grifols
Kedrion
Novo Nordisk
Pfizer
Roche
Sobi
Takeda